(PharmaNewsWire.Com, December 22, 2017 ) A new research report highlighting the broader developments in gene expression analysis market has been added to the comprehensive database of Market Research Hub (MRH). According to the report titled “Gene Expression Analysis Market: Global Industry Analysis 2012-2016 and Forecast 2017-2022”, the global gene expression analysis market is likely to witness a steady growth rate and surpass US$ 4.5 Bn in revenues by the end of 2022. The report offers detailed insights and analysis on the key factors that are likely to drive the global gene expression analysis market during the assessment period.
According to the report, the adoption of gene expression analysis will be influenced by a range of factors including growing focus on the healthcare development in developing countries. Many countries in Asia Pacific are now turning their attention to revamping their healthcare infrastructure and provide a higher quality of care to their citizens. This has led to progress in a number of healthcare related fields which is likely to have a positive influence on the gene expression analysis market during the assessment period.
The report opines that North America will continue to be a leading market for gene expression analysis during the assessment period. The adoption of gene expression analysis in North America will be led by adoption in the US. A number of companies in the gene expression analysis market are based in the US. Also, research institutes that carry out R&D on the advancements in gene expression are also based in the US, which has led to a high degree of awareness among end-users. Use of gene expression analysis in drug discovery is likely to create future growth opportunities for companies based in the region.
In addition to North America, the Asia Pacific excluding Japan (APEJ) is also likely to emerge as a prime destination for gene expression analysis market during the forecast period. In both North America and APEJ, northern blotting technology is gaining steady traction in the process of gene expression analysis. Other key technologies include DNA microarrays and PCR techniques. The drug delivery application segment of gene expression analysis market is likely to remain lucrative during the forecast period as well. This segment is likely to reach a value of over US$ 1.2 Bn during the assessment period.
Some of the leading companies profiled in the report include General Electric Company, Bio-Rad Laboratories, Inc., Luminex Corporation, Oxford Gene Technology IP, Agilent Technologies, Inc., Roche Holding AG, Illumina, Inc., PerkinElmer, Inc., QIAGEN NV, and Thermo Fisher Scientific, Inc.
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of healthcare market reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: